Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer-Reference-Cited by-同舟云学术

Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer

Published:2009-07-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lambin Philippe¹,Ramaekers Bram LT¹,van Mastrigt Ghislaine APG¹,Van den Ende P¹,de Jong J¹,De Ruysscher Dirk K M¹,Pijls-Johannesma Madelon¹

Affiliation:

1. GROW Research Institute; Department of Radiation Oncology (MAASTRO Clinic); University Medical Center Maastricht Netherlands

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006158.pub2/fullpdf

Reference40 articles.

1. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial;Henke;Lancet,2003

2. Luksenburg H Weir A Wager R Treatment of anemia associated with cancer chemotherapy FDA briefing document; http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/4037B2_04_FDA-Aranesp-Procrit.doc 2004 43 9

3. Hoskin PJ Morgan DAL Robinson M Slevin N Hope E Erythropoetin supplementation for radical radiotherapy in head and neck cancer: interim analysis of a randomised phase III trial Estro 21 abstract book Prague 2002 S175

4. Luksenburg H Weir A Wager R Treatment of anemia associated with cancer chemotherapy FDA briefing document; http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/4037B2_04_FDA-Aranesp-Procrit.doc 2004 59 60

5. Luksenburg H Weir A Wager R Treatment of anemia associated with cancer chemotherapy FDA briefing document http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/4037B2_04_FDA-Aranesp-Procrit.doc 2004 61 64

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A radiobiological perspective on radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma;Reports of Practical Oncology and Radiotherapy;2024-02-16

2. Impact of formulation on solid oxygen‐entrapping materials to overcome tumor hypoxia;Journal of Biomedical Materials Research Part A;2024-01-17

3. Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected Pancreatic Cancer;Journal of the National Comprehensive Cancer Network;2024-01

4. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-06-20

5. Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma;Medicine;2022-04-22